These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Diffuse liver uptake on (99m)Tc-MDP bone scan secondary to severe hepatic failure. Chen P, Marentis T, Brown RK. Clin Nucl Med; 2014 Jul; 39(7):658-9. PubMed ID: 24873795 [Abstract] [Full Text] [Related]
33. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging? Kumar V, Kumar D, Howman-Giles RB, Little DG. Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350 [Abstract] [Full Text] [Related]
34. 99mTc-MDP as an imaging tool to evaluate the in vivo biodistribution of solid lipid nanoparticles. Mandiwana V, Kalombo L, Grobler A, Zeevaart JR. Appl Radiat Isot; 2018 Nov; 141():51-56. PubMed ID: 30170270 [Abstract] [Full Text] [Related]
37. Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma. Wilkinson RH, Gaede JT. J Nucl Med; 1979 Apr; 20(4):303-5. PubMed ID: 317096 [Abstract] [Full Text] [Related]
38. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy. Qiu L, Tang Y, Chen Y, Huang Z, Zhu Y, Zhang L, Cai L, Wan Q, Feng Y. Contrast Media Mol Imaging; 2015 Apr; 10(6):438-45. PubMed ID: 26036779 [Abstract] [Full Text] [Related]